Gonorrhea
Pipeline by Development Stage
Drug Modality Breakdown
On Market (1)
Approved therapies currently available
Competitive Landscape
8 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Clinical Trials (12)
Total enrollment: 1,442,810 patients across 12 trials
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Washington State Community Expedited Partner Treatment (EPT) Trial
A Study Evaluating Efficacy and Safety of Gepotidacin Compared With Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea
Antibacterial Mouthwash for Pharyngeal Gonorrhea Prevention
A Dose-Ranging Study Evaluating the Efficacy, Safety, and Tolerability of GSK2140944 in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria Gonorrhoeae
Study to Investigate Effect of Food and Safety of a New Formulation of Zoliflodacin
A Study to Learn About How Trumenba Vaccine Shots Work Against Gonorrhea Infection in Teenagers and Young Adults in the United States.
Pay-it-forward Gonorrhea and Chlamydia Testing Among Men in China
Adolescent Sexually Transmitted Infection Screening in the Emergency Department
Cepheid Rectal Sample Validation Study
Expedited Partner Therapy for MSM in Peru
A Validation Study for Detecting Chlamydia and Gonorrhea in Rectal Samples
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.